As per one of my prior posts, on an EBITDA basis, the stock is undervalued (provided there are no further earnings downgrades). On a NPAT basis, I think it is fairly valued.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game